1 Hahn F, "Primary lung neoplasia in a beagle colony" 33 : 633-638, 1996
2 Knapp DW, "Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors" 29 : 214-218, 1992
3 Rudin CM, "Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer" 8 : 619-623, 2013
4 Horsman MR, "Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies" 66 : 11520-11539, 2006
5 Kim DJ, "Openlabel, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma" 32 : 745-751, 2014
6 Thun MJ, "Nonsteroidal antiinflammatory drugs as anticancer agents : mechanistic, pharmacologic, and clinical issues" 94 : 252-266, 2002
7 Aftab BT, "Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer" 71 : 6764-6772, 2011
8 Devesa SS, "International lung cancer trends by histologic type : male : female differences diminishing and adenocarcinoma rates rising" 117 : 294-299, 2005
9 Boria PA, "Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs" 224 : 388-394, 2004
10 Mohammed SI, "Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer" 62 : 356-358, 2002
1 Hahn F, "Primary lung neoplasia in a beagle colony" 33 : 633-638, 1996
2 Knapp DW, "Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors" 29 : 214-218, 1992
3 Rudin CM, "Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer" 8 : 619-623, 2013
4 Horsman MR, "Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies" 66 : 11520-11539, 2006
5 Kim DJ, "Openlabel, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma" 32 : 745-751, 2014
6 Thun MJ, "Nonsteroidal antiinflammatory drugs as anticancer agents : mechanistic, pharmacologic, and clinical issues" 94 : 252-266, 2002
7 Aftab BT, "Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer" 71 : 6764-6772, 2011
8 Devesa SS, "International lung cancer trends by histologic type : male : female differences diminishing and adenocarcinoma rates rising" 117 : 294-299, 2005
9 Boria PA, "Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs" 224 : 388-394, 2004
10 Mohammed SI, "Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer" 62 : 356-358, 2002
11 Hida T, "Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines" 6 : 2006-2011, 2000
12 Ogilvie G, "Classification of primary lung tumors in dogs : 210 cases(1975-1985)" 195 : 106-108, 1989
13 Moulton J, "Classification of lung carcinomas in the dog and cat" 18 : 513-528, 1981
14 Sandler AB, "COX-2 inhibition and lung cancer" 31 : 45-52, 2004
15 Andersen S, "Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy" 4 : 463-471, 2009